GSA Capital Partners LLP Grows Holdings in CME Group Inc. (NASDAQ:CME)

GSA Capital Partners LLP boosted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 106.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 3,384 shares of the financial services provider’s stock after purchasing an additional 1,742 shares during the period. GSA Capital Partners LLP’s holdings in CME Group were worth $747,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Capital International Investors boosted its stake in shares of CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after buying an additional 3,069,806 shares during the period. Ameriprise Financial Inc. lifted its position in CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after acquiring an additional 537,758 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd grew its stake in shares of CME Group by 1.1% in the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock valued at $863,112,000 after purchasing an additional 43,293 shares during the last quarter. Raymond James & Associates increased its holdings in shares of CME Group by 3.2% in the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after purchasing an additional 94,302 shares during the period. Finally, Legal & General Group Plc increased its holdings in shares of CME Group by 6.6% in the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock valued at $557,371,000 after purchasing an additional 176,004 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CME has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft decreased their price target on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a report on Monday, November 11th. Citigroup raised their target price on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research note on Thursday, October 24th. TD Cowen assumed coverage on shares of CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 price target on the stock. Bank of America raised their price objective on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Finally, Barclays boosted their target price on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 24th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus target price of $224.47.

CME Group Stock Up 0.8 %

CME opened at $225.28 on Monday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market cap of $81.18 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 5.20 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36. The business’s fifty day moving average is $222.62 and its two-hundred day moving average is $210.39.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.25 EPS. Analysts anticipate that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. CME Group’s dividend payout ratio is presently 48.37%.

Insider Activity

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 12.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy S. Bitsberger sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total transaction of $226,960.00. Following the completion of the transaction, the director now directly owns 10,589 shares of the company’s stock, valued at approximately $2,403,279.44. This represents a 8.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 over the last ninety days. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.